Bulletin
Investor Alert

Sanofi

OTC: SNYNF

GO
/marketstate/country/us

Market closed

 --Quotes are delayed by 20 min

Jun 7, 2023, 2:34 p.m.

/zigman2/quotes/205505035/composite

$

100.65

Change

-0.60 -0.59%

Volume

Volume 411

Quotes are delayed by 20 min

/zigman2/quotes/205505035/composite

Previous close

$ 101.25

$ 100.65

Change

-0.60 -0.59%

Day low

Day high

$100.65

$100.65

Open

52 week low

52 week high

$73.31

$114.90

Open

Carole Gabriella Ferrand

Currently, Carole Gabriella Ferrand is Chief Financial Officer of Capgemini SE, Chief Financial Officer for Capgemini Group, Chairman for Isai Cap Venture and Chief Finance Officer & General Secretary at Sony France SA. She is also on the board of 9 other companies.

In the past she occupied the position of Financing Director at Financière Pinault SCA, Chief Financial Officer at EuropaCorp SA, Chief Financial Officer of Capgemini Technology Services India Ltd., Chief Financial Officer & General Counsel at Sony Semiconductor Kyusyu Corp. and Auditor at PricewaterhouseCoopers France SARL.

Carole Gabriella Ferrand received an undergraduate degree from École des Hautes Études Commerciales de Paris.

Transactions

Date Shares Transaction Value
09/06/2022 1   Acquisition at $80.62 per share. 80

Officers and Executives

Mr. Serge Weinberg
Honorary Chairman
Mr. Paul Hudson
Chief Executive Officer & Director
Mr. Jean-Baptiste Chasseloup de Chatillon
Chief Financial Officer & Executive Vice President
Dr. Dietmar P. Berger
Chief Medical Officer & Global Head-Development
Dr. Nestle Frank
Global Head-Immunology Therapeutic Research Area
Ms. Julie van Ongevalle
Executive VP & Head-Consumer Healthcare
Mr. William J. Sibold
EVP-Specialty Care & President-North America
Ms. Alexandra Roger
Head-Securities Law & Capital Markets
Mr. Brendan OCallaghan
Executive Vice President & Head-Industrial Affairs
Mr. Josep Catlla
Head-Communication
Mr. Raj Verma
Chief Diversity, Culture & Experience Officer
Mr. Olivier Antoine M. Charmeil
Executive Vice President-General Medicines
Mr. Yann Tran
Director
Dr. Wolfgang Laux
Director
Mr. Christophe Babule
Director
Ms. Eva Schäfer-Jansen
Head-Investor Relations
Ms. Natalie Bickford
Chief People Officer & Executive Vice President
Ms. Claire Terrazas
Vice President-Corporate Legal Affairs
Mr. Roy Papatheodorou
EVP, General Counsel & Head-Legal
Mr. Arnaud Delépine
Investor Relations Contact
Mr. Frédéric Oudéa
Chairman
Ms. Rachel Duan
Independent Non-Executive Director
Ms. Lise Kingo
Independent Director
Mr. Gilles Schnepp
Independent Director
Ms. Barbara Lavernos
Independent Director
Ms. Carole Gabriella Ferrand
Independent Director
Dr. Emile Voest
Independent Director
Dr. Antoine Yver
Independent Director
Ms. Fabienne Lecorvaisier
Independent Director
Mr. Patrick Kron
Independent Director
Ms. Diane D. Souza
Independent Director
Dr. Thomas C. Südhof
Independent Director
Link to MarketWatch's Slice.